Alnylam Pharmaceuticals
ALNY
#619
Rank
โ‚ฌ36.50 B
Marketcap
273,40ย โ‚ฌ
Share price
3.68%
Change (1 day)
-0.63%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no dividend history for this company